Givaudan SA

BIT:1GIVN Stock Report

Market Cap: €28.9b

Givaudan Valuation

Is 1GIVN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Future Cash Flow Value

What is the Fair Price of 1GIVN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: 1GIVN (€3140) is trading below our estimate of future cash flow value (€3640.98)

Significantly Below Future Cash Flow Value: 1GIVN is trading below future cash flow value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 1GIVN?

Key metric: As 1GIVN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 1GIVN. This is calculated by dividing 1GIVN's market cap by their current earnings.
What is 1GIVN's PE Ratio?
PE Ratio24.4x
EarningsCHF 1.07b
Market CapCHF 26.11b

Price to Earnings Ratio vs Peers

How does 1GIVN's PE Ratio compare to its peers?

The above table shows the PE ratio for 1GIVN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average21.5x
SOL SOL
30.3x9.82%€4.7b
BZU Buzzi
8.8x-0.11%€8.0b
SIKA Sika
21.7x9.70%CHF 22.6b
600309 Wanhua Chemical Group
25.2x24.85%CN¥276.1b
1GIVN Givaudan
24.4x5.93%€26.1b

Price-To-Earnings vs Peers: 1GIVN is expensive based on its Price-To-Earnings Ratio (24.4x) compared to the peer average (21.4x).

Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

Fetching historical data

Price to Earnings Ratio vs Industry

How does 1GIVN's PE Ratio compare vs other companies in the European Chemicals Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
1GIVN 24.4xIndustry Avg. 18.6xNo. of Companies12PE01224364860+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 1GIVN is expensive based on its Price-To-Earnings Ratio (24.4x) compared to the European Chemicals industry average (18.1x).

Price to Earnings Ratio vs Fair Ratio

What is 1GIVN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

1GIVN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio24.4x
Fair PE Ratio22.8x

Price-To-Earnings vs Fair Ratio: 1GIVN is expensive based on its Price-To-Earnings Ratio (24.4x) compared to the estimated Fair Price-To-Earnings Ratio (22.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 1GIVN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€3,140.00
€3,993.92
+27.19%
12.71%€5,294.14€3,198.54n/a19
Mar ’27€3,400.00
€3,984.39
+17.19%
12.71%€5,281.51€3,190.91n/a19
Feb ’27€3,240.00
€4,134.77
+27.62%
13.46%€5,497.71€3,163.36n/a20
Jan ’27€3,380.00
€4,250.73
+25.76%
13.34%€5,411.61€3,328.57n/a19
Dec ’26€3,640.00
€4,312.26
+18.47%
11.68%€5,404.79€3,538.85n/a19
Nov ’26€3,560.00
€4,321.53
+21.39%
12.69%€5,437.76€3,560.44n/a19
Oct ’26€3,420.00
€4,295.84
+25.61%
12.89%€5,389.07€3,528.56n/a19
Sep ’26€3,660.00
€4,406.57
+20.40%
12.01%€5,381.47€3,416.81n/a20
Aug ’26€3,600.00
€4,471.30
+24.20%
11.59%€5,434.26€3,450.32n/a20
Jul ’26€4,160.00
€4,501.54
+8.21%
10.17%€5,395.12€3,746.61n/a21
Jun ’26€4,440.00
€4,463.00
+0.52%
9.81%€5,395.73€3,747.04n/a21
May ’26n/a
€4,435.01
0%
10.14%€5,380.95€3,662.04n/a21
Apr ’26n/a
€4,419.99
0%
11.40%€5,329.43€3,479.80n/a21
Mar ’26n/a
€4,440.22
0%
11.04%€5,402.37€3,527.43€3,400.0020
Feb ’26n/a
€4,395.13
0%
10.92%€5,402.29€3,527.38€3,240.0020
Jan ’26n/a
€4,470.23
0%
10.76%€5,464.31€3,567.87€3,380.0020
Dec ’25n/a
€4,481.36
0%
10.77%€5,472.60€3,573.29€3,640.0020
Nov ’25n/a
€4,499.16
0%
10.16%€5,458.63€3,564.16€3,560.0021
Oct ’25n/a
€4,400.23
0%
9.90%€5,220.19€3,385.61€3,420.0022
Sep ’25n/a
€4,285.03
0%
10.93%€5,077.38€3,139.35€3,660.0022
Aug ’25n/a
€4,285.03
0%
10.93%€5,077.38€3,139.35€3,600.0022
Jul ’25n/a
€4,101.36
0%
11.50%€4,950.16€3,093.85€4,160.0021
Jun ’25n/a
€3,872.23
0%
12.07%€4,738.33€2,822.84€4,440.0021
May ’25n/a
€3,917.67
0%
11.80%€4,839.17€2,882.91n/a21
Apr ’25n/a
€3,719.29
0%
13.08%€4,734.67€2,881.97n/a21
Mar ’25n/a
€3,569.91
0%
11.08%€4,362.72€2,936.45n/a21
€4.02k
Fair Value
21.9% undervalued intrinsic discount
19
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/10 08:07
End of Day Share Price 2026/03/10 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Givaudan SA is covered by 36 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Volker BosseBaader Helvea Equity Research
Konstantin WiechertBaader Helvea Equity Research
Robert BateBarclays